10-Minute fetal monitor could speed up labor care
NCT ID NCT07250620
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a 10-minute cardiotocography (CTG) test can accurately check fetal well-being during labor, compared to the standard 30-minute test. Researchers will enroll 200 low-risk pregnant women in active labor at a hospital in Egypt. If the shorter test works well, it could reduce waiting times and ease the workload for healthcare staff.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, a 10-minute CTG could replace the standard 30-minute test, speeding up care and reducing delays in busy labor wards.
- What could go wrong
- This is a small, early-stage study with 200 low-risk women. The shorter test may be less accurate in detecting fetal distress, and results may not apply to high-risk pregnancies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 200 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Dec 2025
An estimate. Start dates often move.
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
All women who come to Women's Health Assiut university hospital in labor and meet the inclusion criteria after informed consent.
- Ages
-
18 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Singleton pregnancy. * Gestational age ≥ 37 weeks. * Vertex presentation. * Active first stage of labor (cervical dilation ≥ 4 cm). * Low-risk pregnancy (no hypertension, diabetes, IUGR, or other significant complications). Exclusion Criteria: * • Multiple gestation. * Known major fetal anomaly. * Non-vertex presentation. * Indication for continuous CTG (e.g., meconium-stained liquor, antepartum hemorrhage). * Maternal refusal.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Labor active dilated CM are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.